A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)

NCT04009681 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
175
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated as per Sponsor decision. The decision was not related to any safety concerns.

Conditions

Interventions

Sponsor

Synthorx, Inc, a Sanofi company